Clinical Trial Update: A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating nedaplatin for locoregionally advanced nasopharyngeal carcinoma, sponsored by Guangxi Medical University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Nedaplatin (nedaplatin)

Snippet

Sponsor: Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN